$0.02
+ $0.01 (100.00%)
End-of-day quote: 05/20/2024
OTCPK:PKTX

ProtoKinetix Profile

ProtoKinetix, Incorporated (ProtoKinetix) operates as a research and development stage bio-technology company. The company focuses on scientific medical research of AFGPs (Anti-Freeze Glycoproteins) or anti-aging glycoproteins, trademarked as AAGPs.

The company has been in the process of directing major efforts to the practical side of commercial validation. The commercial applications for AAGPs in large markets, such as targeted health care solutions are numerous. ProtoKinetix is working with researchers, business leaders and advisors and commercial entities to bring AAGP to market.

Research and Development

For the year ended December 31, 2022, the company incurred total research and development expenses of $448,873.

History

The company was founded in 1999. It was incorporated under the laws of the state of Nevada in 1999. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in 2003.

Country
Industry:
Biological Products, Except Diagnostic Substances
Founded:
1999
IPO Date:
01/07/2002
ISIN Number:
I_US7437221002

Contact Details

Address:
109 W Main St, Dalton, Ohio, 44618, United States
Phone Number
330 455 4971

Key Executives

CEO:
Smith, Clarence
CFO
Guzzetta, Michael
COO:
Data Unavailable